|
Volumn 38, Issue 10, 2006, Pages 707-
|
Acute renal failure following myeloablative autologous and allogeneic hematopoietic cell transplantation [4]
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BUSULFAN;
CARBOPLATIN;
CARMUSTINE;
CREATININE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
ETOPOSIDE;
MELPHALAN;
PROSTAGLANDIN E1;
ACUTE KIDNEY FAILURE;
ADULT;
ADVANCED CANCER;
AGE;
ALLOGENEIC STEM CELL TRANSPLANTATION;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BONE MARROW TRANSPLANTATION;
COMORBIDITY;
CONTINUOUS HEMODIAFILTRATION;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
FEMALE;
GENDER;
GRAFT VERSUS HOST REACTION;
HEMODIALYSIS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
LETTER;
LIVER VEIN OBSTRUCTION;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE MYELOMA;
NEPHROTOXICITY;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SEPTIC SHOCK;
ADULT;
COHORT STUDIES;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
KIDNEY FAILURE, ACUTE;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
RISK FACTORS;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, AUTOLOGOUS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 33750572108
PISSN: 02683369
EISSN: 14765365
Source Type: Journal
DOI: 10.1038/sj.bmt.1705513 Document Type: Letter |
Times cited : (31)
|
References (5)
|